Modavar Pharmaceuticals' headquarters is located in the heart of Washington, D.C.
In collaboration with Cadila Pharmaceuticals Limited, Modavar has a strong pipeline of products, and plans to manufacture ANDA and 505(b)(2) products in its FDA approved Frederick, Maryland plant as well.
Modavar is committed to supplying affordable, quality formulations using some of the most innovative research methods and cutting-edge manufacturing processes.
We will discover, develop and successfully market pharmaceutical products to prevent and manage diseases to increase quality of life.
